Antiepileptic drugs and atypical evolution of idiopathic partial epilepsy

被引:53
|
作者
Prats, JM [1 ]
Garaizar, C
García-Nieto, ML
Madoz, P
机构
[1] Hosp Cruces, Div Pediat Neurol, Dept Pediat, Neuropediat Unit, Baracaldo 48903, Vizcaya, Spain
[2] Hosp Cruces, Neurophysiol Serv, Baracaldo 48903, Vizcaya, Spain
关键词
D O I
10.1016/S0887-8994(97)00223-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Six patients with classic benign epilepsy of childhood with centrotemporal spikes, treated with carbamazepine (four patients) or sodium valproate (two patients) evolved atypically because the epileptic disorder, diffusion of the electroencephalographic (EEG) discharges during wakefulness, and continuous spike-and-wave during slow sleep associated with severe neuropsychologic abnormalities worsened. These features appeared after a seizure-free interval varying for 2 weeks to 1 year 6 months after initiating therapy and remitted when the previous anticonvulsant drug was discontinued and either substituted with another drug or the patient was left without any treatment. Once the initial antiepileptic drug was discontinued and after a period roughly proportional to the duration of the clinical-EEG complication, the evolution of the patients' seizures was not unusual for this type of epilepsy, with patients eventually becoming free of both seizures and medication and reaching normal school achievement, The clinical complications cannot be attributed solely to the drugs. It must also be related to the underlying substract (i.e., the specific epileptic syndrome involved) that in some patients becomes susceptible to atypical evolution when either product is administered. (C) 1998 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:402 / 406
页数:5
相关论文
共 50 条
  • [21] Oxcarbazepine and atypical evolution of benign idiopathic focal epilepsy of childhood
    Grosso, S.
    Balestri, M.
    Di Bartolo, R. M.
    Corbini, L.
    Vatti, G.
    Curatolo, P.
    Balestri, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (10) : 1142 - 1145
  • [22] Epilepsy, antiepileptic drugs and suicidality
    Bagary, Manny
    CURRENT OPINION IN NEUROLOGY, 2011, 24 (02) : 177 - 182
  • [23] A critical overview on epilepsy overtreatment with antiepileptic drugs - Are patients with epilepsy presently overtreated with antiepileptic drugs?
    Schmidt, D
    NERVENHEILKUNDE, 2002, 21 (08) : 426 - 431
  • [24] Meta-analyses of antiepileptic drugs for refractory partial (focal) epilepsy: an observation
    Brodie, Martin J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (05) : 630 - 631
  • [25] Outcomes of add on treatment with new generation antiepileptic drugs for partial epilepsy patients
    Nikodijevic-Kedeva, D
    Petrovska, D
    Dzonov, I
    Cvetkovska, E
    Pashu, M
    EPILEPSIA, 2004, 45 : 125 - 125
  • [26] Plasma carnitine levels in children with idiopathic epilepsy treated with old and new antiepileptic drugs
    El-Aziz, Sahar A. Abd
    El-Serogy, Hesham
    JOURNAL OF PEDIATRIC NEUROLOGY, 2012, 10 (04) : 275 - 281
  • [27] Comparing the effects of first-line antiepileptic drugs on the gait of dogs with idiopathic epilepsy
    Suiter, E. J.
    Packer, R. M. A.
    Volk, H. A.
    VETERINARY RECORD, 2016, 178 (26) : 652 - +
  • [28] Effects of epilepsy and antiepileptic drugs on nitric oxide, lipid peroxidation and xanthine oxidase system in children with idiopathic epilepsy
    Arhan, Ebru
    Serdaroglu, Ayse
    Ozturk, Bahadir
    Ozturk, H. Serdar
    Ozcelik, Aysima
    Kurt, Nese
    Kutsal, Ebru
    Sevinc, Neriman
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2011, 20 (02): : 138 - 142
  • [29] Adherence to antiepileptic drugs in adolescents with epilepsy
    Smith, Aimee W.
    Mara, Constance A.
    Modi, Avani C.
    EPILEPSY & BEHAVIOR, 2018, 80 : 307 - 311
  • [30] PROGNOSIS OF EPILEPSY WITH DISCONTINUOUS OF ANTIEPILEPTIC DRUGS
    TAKAYAMA, K
    ISHIDA, S
    SAKURAI, S
    RYU, H
    MAEDA, H
    NAKAZAWA, Y
    EPILEPSIA, 1995, 36 : S165 - S165